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Abstract--We have examined the ability of  SV40 to induce changes in drug or temperature 
resistance in mouse, hamster, and mouse-human hybrid cells. SV40 induced a substantial 
increase of cells resistant to 5-bromodeoxyuridine + trifluorothymidine in Balb/c 3T3 cells and 
induced an increase of hybrid cells" resistant to 6-thioguanine. SV40 was found to be nonmutagenic 
or weakly mutagenic in other test .systems'. The 3T3 cells were T-antigen positive, exhibited a 
marked reduction in TK activity, were heterogeneous for FH]BrdU incorporation by autoradiogra- 
phy, and exhibited instability of the drug-resistance phenotype, suggesting that SV40 may be 
inducing resistance by an epigenetic process. SV40-induced 6-thioguanine resistance in the hybrids 
appears to occur predominantly by chromosome loss. 
INTRODUCTION 
SV40 interacts with cells that are not 
permissive for viral replication in several 
ways. In many infected ceils, abortive trans- 
formation occurs: the viral T antigens are 
expressed; synthesis of cellular DNA is 
stimulated; and a limited number of cell 
divisions are induced. In a fraction of 
infected nonpermissive cells, SV40 DNA is 
inserted into the cellular DNA. If the portion 
of the integrated viral DNA encoding large T 
antigen is expressed, the cell becomes stably 
transformed and continues to exhibit altered 
growth properties. If the integrated viral 
DNA is not expressed as functional large T 
antigen, the cell remains cryptically trans- 
formed (1). The integration of viral DNA in 
both overt and cryptic transformants might 
be expected on occasion to disrupt cellular 
genes, either during initial insertion into the 
host genome or during subsequent rearrange- 
ments occurring in SV40-transformed cells 
(2, 3). 
SV40 has been reported to induce 
chromosome and karyotype abnormalities 
(4-8). Some of these chromosome aberra- 
tions may result in inactivation of host genes 
or other alterations in host gene expression. 
Specific chromosome aberrations in human 
cells transfected with origin defective SV40 
have been associated with immortitization 
(9) and tumorigenicity (10). 
Mutations at several different selectable 
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loci have been reported to be induced shortly 
after SV40 infection of mouse, hamster, and 
human cells (7, 11-13). These mutagenic 
effects are variable. Investigators have re- 
ported no mutagenic effect of SV40 in some 
experiments and 12-fold or greater increases 
in the frequency of mutants in other experi- 
ments. Conflicting results have been ob- 
tained regarding the role of T antigen in 
SV40-mediated mutagenesis (13, 15-16). 
The underlying mechanism(s) of these muta- 
genic effects of SV40 is not known. 
Vogt and Dulbecco (17) proposed the 
hypothesis that mutagenic effects of papova- 
viruses may play a role in transformation and 
tumorigenesis. Our studies were initiated to 
gain a better understanding of the nature of 
SV40-induced mutagenesis and the role 
SV40 mutagenesis might play in T-antigen- 
independent SV40-mediated cell transforma- 
tion. 
We examined the ability of SV40 to 
induce mutants resistant to six different 
selection conditions in a variety of mamma- 
lian cells. We found that, in most instances, 
infection by SV40 does not increase the 
frequency of mutants above the spontaneous 
frequency seen in uninfected cells. We have, 
however, detected two noteworthy instances 
of SV40-induced drug resistance: one ap- 
pears to represent an epigenetic phenome- 
non and the other to be the result of whole 
chromosome loss. In the first case, infection 
with SV40 produced a striking induction of 
Balb/c 3T3 cells resistant to the pyrimidine 
analogs 5-bromodeoxyuridine (BrdU) and 
trittuorothymidine (TFT). The second in- 
stance of SV40 mutagenesis was noted when 
interspecific hybrid cells infected with SV40 
were observed to lose two distinct human X 
chromosome loci coordinately. Instability of 
the BrdU~FT-resistant mutants suggests 
that on occasion SV40 may induce epigenetic 
events that confer drug resistance. The 
coordinate loss of two selectable markers on 
the same human chromosome from the 
hybrid cells indicates that SV40 may induce 
whole chromosome loss. 
MATERIALS AND METHODS 
Cells. The origins of the untransformed 
heteroploid Balb/c 3T3 cells (Bc3T3) and 
BSC-1 cells have been described elsewhere 
(18, 19). CHEF/t8 cells are normal diploid 
Chinese hamster cells (20). LMTK-APRT- 
cells are chemically transformed heteroploid 
mouse strain L cells (21-23) resistant to 
BrdU (24, 25) and diaminopurine (26). 
tsCIAG ~ is a heat-sensitive, azaguanine- 
resistant mutant derived from mouse L cells 
(27). The 462-10 near-diploid spontaneously 
transformed Chinese hamster cells (28) are 
resistant to BrdU and deficient in thymidine 
kinase (TK-). CHO-K1 (CCL61) near- 
diploid spontaneously transformed Chinese 
hamster cells were obtained from the Ameri- 
can Type Culture Collection (12301 Park- 
lawn Dr., Rockwille, Maryland 20852). The 
origin and characteristics of 157BnpT-1, a 
heteroploid mouse-human hybrid cell line 
(tsCIAG a X GM126), have been described 
(29). 157BnpT-1B is a subclone of 157BnpT-1, 
and BSC-1E is a subctone of BSC-1. Cells 
were grown in 5 ml/25 cm 2 c~-MEM supple- 
mented with 10% fetal or calf bovine serum 
and were equilibrated with 5% CO2 in air. 
Virus. SV40 strain 776 (18, 19) was 
propagated on BSC-1 or BSC-1E cells at a 
multiplicity of infection of 1.0-2-10 3 plaque- 
forming units (PFU) per cell to obtain a 
crude cell lysate that was concentrated by 
either: polyethylene glycol precipitation (30); 
pH 5.6 precipitation (Course Manual: Ani- 
mal Virus Course, Cold Spring Harbor 
Laboratory, Cold Spring Harbor, New York 
11724, H. Diggelmann and P. Beard, pp. 5-6, 
1976); or a modification of the pH 5.6 
procedure. The modified pH 5.6 procedure 
was as follows: (1) When approximately 90% 
of the cells exhibited typical SV40 CPE, the 
cultures were frozen and thawed three times 
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and the debris collected by scraping with a 
rubber policeman into medium containing 
2% fetal bovine serum (FBS). (2) The 
medium was acidified by adding 1/50 to 1/100 
vol of 2 M KNa2PO 4 pH 5.6. (3) The acidified 
crude lysate was incubated overnight at 4°C. 
(4) Virus was pelleted by centrifugation at 
8000g for 40 min at 4°C and resuspended in 
1/40 volume of medium with 2% FBS. (5) 
The concentration of NaHCO 3 was adjusted 
to 50 mM with 7.5% NaHCO 3 and the virus 
suspension was stirred overnight at 4°C. (6) 
The resuspended virus concentrate was soni- 
cated at full power using a Heat Systems 
model W375 with a 431A cup horn for 3 min 
at room temperature. (7) The sonicated virus 
concentrate was centrifuged at 8000g for 10 
min at 37°C. The supernatant was collected 
and saved and the pellet resuspended in 
medium with 2% FBS and 50 mM NaHCO3 
(half the volume of the step 6 virus concen- 
trate), sonicated, and centrifuged as de- 
scribed. The second supernatant was added 
to the first step 7 supernatant. Virus concen- 
trates produced by this procedure yielded 
titers ranging from 1.7 to 9.5 x 101° PFU/ml. 
Mock-infected BSC-1 cells were frozen and 
thawed three times in medium with 2% fetal 
bovine serum to produce a mock lysate. A 
mock lysate processed by the modified pH 
5.6 procedure gave rise to the mock lysate 
concentrate. 
Infection Protocol. Medium was re- 
moved from monolayers, and virus was 
added at a multiplicity of infection ranging 
from 102 to 8 × 104 in a volume of 0.2-.3.0 
ml/25 cm 2 for 2-5 h. After infection, growth 
medium was added without removing unab- 
sorbed virus. 
Drug Selection Systems. Drug selection 
systems used were: 6-thioguanine (6TG, 25 
ixg/ml) for loss of hypoxanthine-guanine 
phosphoribosyltransferase (HPRT); BrdU 
(30 l~g/ml) and TFT (1 ~g/ml) were used in 
combination for stringent selection for loss of 
TK; and cytosine arabinoside (araC, 1 txg/ml) 
for loss of deoxycytidine kinase (dCK). HAT 
medium (hypoxanthine, 10 .4 M; aminop- 
terin, 4 x 10 .7 M;  and thymidine, 1.6 x 10 -5 
M) was used to select for TK + cells. Colonies 
were stained with Wright's stain. 
Temperature Selection. tsCIAG R cells and 
157BnpT-1 mouse-human hybrids that lack 
the heat-resistance locus hrCl (CIHR, Hu- 
man Gene Mapping Conference, 31) located 
on the human X chromosome are killed at 
the nonpermissive temperature (npT) of 
38.5°C, but grow at the permissive tempera- 
ture (pT) of 34°C (29). 157BnpT-1 and 
derivatives that have the human X chromo- 
some grow at both the permissive tempera- 
ture and nonpermissive temperature, as do 
heat-resistant revertants of tsCIAG R. Hy- 
brids that grow in TG at the nonpermissive 
temperature represent presumptive X chro- 
mosome rearrangement events or mutation 
at the HPRT locus. Hybrids that grow in 6TG 
at the permissive temperature and are heat 
sensitive without selection for loss of the hrCl 
locus represent presumptive human X chro- 
mosome loss events. 
Chromosome Loss Test. To test for 
whole chromosome loss, mouse-human hy- 
brid cells grown under selective conditions to 
fix the human X chromosome markers are 
shifted to nonselective conditions and ex- 
posed to the test agent for a specific time 
(time of treatment). The time of treatment 
was typically five days for virus, cotchicine, or 
colcemid. After treatment, the cells are 
grown under nonselective conditions in the 
absence of the test agent for a specific time 
(time of expression) to permit the phenotypic 
expression of any mutations induced during 
the treatment period. After the expression 
period, the cells are selected in 6TG at the 
permissive temperature or nonpermissive 
temperature for a period of approximately 10 
days to two weeks and the frequency of 
colony-forming cells (CFC) is determined at 
the permissive temperature and nonpermis- 
sive temperature. Treatment controls consist 
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of cells treated with medium, with a drug 
known to induce chromosome loss such as 
colchicine or colcemid (32-34), or with a 
mock lysate. Strong presumptive evidence 
for whole human X chromosome loss is that 
the frequency of CFC in 6TG permissive- 
temperature test cultures is greater than the 
frequency of CFC in 6TG permissive- 
temperature control cultures and that the 
frequency of 6TG-resistant cells that are heat 
sensitive in the test cultures is greater than 
the frequency of 6TG resistant cells that are 
heat sensitive in the control cultures. Strong 
evidence for human X chromosome rear- 
rangement or mutagenesis at the structural 
gene locus of human HPRT is that the 
frequency of CFC in 6TG nonpermissive- 
temperature test cultures is greater than the 
frequency of CFC in 6TG nonpermissive- 
temperature control cultures. 
T-Antigen Staining. T-antigen-positive 
cells grown on glass slides were visualized by 
indirect immunofluorescence assay (IFA) 
using anti-SV40 hamster antiserum (Office 
of Program Resources and Logistics, Na- 
tional Cancer Institute) and fluorescein iso- 
thiocyanate-conjugated goat or rabbit anti- 
hamster serum after fixation in acetone at 
-20°C. 
TKAssay. Cells from three 15-cm tissue 
culture dishes were harvested, resuspended 
in 0.5 ml of extraction buffer (10 mM KC1, 1 
mM MgCI 2, 50 lxM thymidine, 3 mM [3-mer- 
captoethanol, and 10 mM Tris HC1, pH 8.0), 
frozen and thawed four times, and centri- 
fuged in a Beckman microfuge at approxi- 
mately 10,000 g for 20 rain at 4°C. The 
supernatant was collected and stored at 
-70°C prior to assay as described (35). 
Protein was assayed by the method of Lowry 
et al. (36). TK activity was expressed as the 
counts per minute per microgram protein per 
30 min relative to Bc3T3 (100%). 
[3H]BrdU Uptake. Cells were seeded 
into 24-well plates at 104 cells/well in growth 
medium and incubated for 24-48 h at 37°C. 
The cells, at approximately 50% confluency, 
were labeled with [3H]BrdU 1 lxCi/ml in 
o~-MEM with 1% fetal calf serum at 37°C. 
Duplicate wells were rinsed three times with 
phosphate-buffered saline, and the cells were 
lysed by the addition of 0.25 ml of 10 mM 
EDTA plus 0.6% SDS (sodium dodecytsul- 
fate). 1Ne lysate was removed and acid 
precipitable radioactivity was determined by 
spotting 0.2 ml of lysate onto a Whatman 
GF/B filter previously soaked in 5% TCA. 
The filter was rinsed extensively with 5% 
TCA, 95% ethanol, dried, and counted in 
nonaqueous scintillation fluid. Incorporation 
of [3H]BrdU by Bc3T3 was linear over at 
least a 4-h time period. [3H]BrdU uptake was 
expressed as the counts per minute per 
milligram protein per hour relative to Bc3T3 
(100%) at the 1-h time point. 
Autoradiography. Cells were grown in 
1.6-cm 2 wells as described above and labeled 
for 10-24 h with 1 ~zCi/ml of [3H]BrdU. The 
medium was removed and the cells washed 
twice with PBS. The cells were fixed with 
100% ethanol-glacial acetic acid (3:1, v/v) for 
5 min followed by 5% TCA for 5 rain. The 
cells were washed three times in 70% ethanol 
and once with 100% ethanol for 10 min each. 
Each well was coated with Kodak NTB2 
emulsion and exposed in a lightproof box 
kept at 4°C for five days. The emulsion was 
developed with Kodak D-19 developer, fixed, 
and the cells were examined using phase- 
contrast microscopy. 
RESULTS 
Expression of T Antigen. Effects of SV40 
were assessed in transformed and untrans- 
formed cells that are either diploid, near 
diploid, or heteroploid (Table 1). T-antigen 
staining was done to determine the infectabil- 
ity of target cells, which should directly affect 
the frequency of cells subject to SV40 
mutagenic effects. This assay depends on the 
ability of infected cells to express the early 
genes of SV40 as well as to take up and 
uncoat SV40 virions. The presence of detect- 
able T antigen varied considerably among 
the various cell lines (Table 1). Spontane- 
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Table 1. Characteristics of Cell Lines and T-Antigen Expression 
T-antigen 
Cell line Chromosome number Growth phenotype expression" 
CHOK1 Near diploid 
Chinese hamster 
462-10 Near diploid 
V79 Derivative Chinese 
hamster 
LMTK Heteroploid 
L derivative mouse 
tsC1 Heteroploid 




Balb c derivative mouse 
157BnpT-1B Heteroptoid, approx. 
Mouse-human hybrid tsCl 80 mouse and 3 
mouse cells × untrans- human chromo- 

















° The frequency of T-antigen-positive cells was determined by IFA five to six days after infection at an MOI of 104. 
ously transformed Chinese hamster cell lines 
and chemically transformed mouse L cell 
lines expressed little or no T antigen. The low 
level of T antigen expression in mouse L cells 
may be due to reduced uptake of SV40, since 
SV40 uptake by L M T K  cells is approxi- 
mately 500-fold less efficient than uptake by 
primary monkey cells and approximately 
120-fold less efficient than uptake by CV-1 
cells (37). Untransformed Chinese hamster 
cells exhibited a moderate  frequency of 
T-antigen-positive cells, while the untrans- 
formed mouse Bc3T3 cells had a high 
frequency of T-antigen-positive cells. The 
mouse-human hybrid cell line exhibited a 
very high frequency of T-antigen-positive 
cells. The  hybrid contained human chromo- 
somes 3, 14, X, and possibly chromosome 15 
in addition to approximately twice the 
number of  mouse chromosomes found in 
tsC1 cells. It is possible that the human 
chromosomes present in the hybrid enable 
these cells to either take up, uncoat, or 
express SV40 more efficiently than the 
parental mouse cells. 
Effect of SV40 on Drug or Temperature 
Resistance in CHOK1, 462-10, LMTK-, tsC1, 
and CHEF Cells. We did not observe SV40 
induction of CHOK1 mutants resistant to 
araC (Table 2). A small increase in the 
frequency of 6TG-resistant cells was noted in 
CHOK1 cells, but the significance of this 
increase is questionable due to the fact that 
the fractional error was high in both the 
control and the infected cultures. The 462-10 
Chinese hamster cells exhibited a modest 
increase in the frequency of araC-resistant 
cells after infection with SV40 (Table 2). 
When SV40-infected 462-10 cells were treated 
with a low concentration of colcemid to 
promote chromosome loss and uncover reces- 
sive mutations, the frequency of araC- 
resistant cells was increased several-fold 
relative to the medium and mock lysate 
controls and the culture treated with SV40 
alone. These results suggest that SV40 may 
induce recessive mutations or cryptic muta- 
genic events that may be uncovered by 
chromosome loss. When SV40-infected 
462-10 cells were selected for resistance to 
6TG, a small increase was noted when the 
infected cells were treated with colcemid. 
The high background frequency of  6TG- 
resistant cells in 462-10 limits the sensitivity 
of this test system. 
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tion to 6TG resistance after infection and 
failed to detect any 6TG-resistant mutants, 
although a reconstruction experiment using a 
defined mixture of 6TG-resistant tsC1 cells 
and 6TG-sensitive LMTK- cells demon- 
strated that 6TG resistant mutants should 
have been recoverable under the conditions 
of this experiment (data not shown). We 
tested heat-sensitive tsC1 mouse cells for the 
presence of mutants resistant to heat after 
infection. SV40 did not enhance the fre- 
quency of heat-resistant revertants (Table 2). 
CHEF cells express a moderate level of 
SV40 T antigen in contrast to CHOK1, 
462-10, LMTK-, and tsC1, which express only 
low levels of T antigen. Three experiments 
with CHEF cells (Table 2) produced no 
evidence for SV40-induced resistance to 
6TG. One infection of CHEF cells at a high 
multiplicity of infection yielded five 6TG- 
resistant clones, none of which expressed 
SV40 T antigen detectable by IFA or 
immunoprecipitation PAGE analysis. 
Induction of Resistance to Thymidine 
Analogs in SV40-Infected Bc3T3 Cells. The 
Bc3T3 line of mouse cells is readily infected 
by SV40. Transformation of Bc3T3 cells has 
been studied extensively (2, 19) and occurs at 
a frequency of 10 -5 transformants/PFU. 
Integration of SV40 DNA in Bc3T3 cells 
occurs at a high frequency (1). After infec- 
tion with SV40, the majority of Bc3T3 cells 
also express T antigen (Table 1). One of 
three plates of SV40 infected Bc3T3 cells 
selected for resistance to BrdU + TFT 
(presumptive TK-) yielded one very large 
colony and several small colonies that may 
have been satellite colonies. A number of 
these BrdU + TFT (BT) -resistant colonies 
were picked and maintained as independent 
cell clones (9C series). All nine clones tested 
were positive for T-antigen expression. When 
9C clones were plated in HAT medium, 
which selects for TK + cells, HAT-resistant 
cultures readily became established in a 
single passage. Subclones isolated from 9C 
primary clones in BT medium exhibited a 
high frequency of HAT-resistant cells (10 3_ 
104), which suggests that the drug-resistance 
phenotype is unstable. Infection of Bc3T3 
cells at a higher multiplicity of infection 
(8.8 x 103) led to an increase in the fre- 
quency of cells resistant to BT (68B series 
cell lines). The 68B series cell lines also 
exhibited a high background frequency of 
HAT-resistant cells. 
BrdU Uptake and TKActivity. To ascer- 
tain the nature of the thymidine analog 
resistance in the SV40-infected Bc3T3 cells, 
we analyzed [3H]BrdU uptake and TK 
activity in BT-resistant cell lines, Bc3T3 cells, 
and SV40-transformed Bc3T3 cells not se- 
lected for drug resistance. [3H]BrdU uptake 
was linear with time and varied in different 
BT-resistance cell lines from 1.2% to 8.7% of 
the uptake exhibited by untransformed Bc3T3 
cells (Table 3). Two SV40-transformed lines, 
not selected for drug resistance, had levels of 
[3H]BrdU uptake of 80% and 130% relative 
to Bc3T3 cells (Table 3), which demon- 
strated that the reduction of BrdU uptake in 
the BT-resistant cells was not a simple 
consequence of SV40 infection, T-antigen 
expression, or SV40-mediated transforma- 
tion. The uptake of [3H]thymidine was 
measured and was found to be proportional 
Table 3. BrdU Incorporation and TK Activity in 9C 
and 68B Clones Resistant to BrdU and TFT 
BrdU incorporation TK activity 
Cells 
cpm/mg Percent b cpm/mg 
protein/h ~ labeled protein/0.5 h 
(% of Bc3T3) nuclei (% of Bc3T3) 
9C-4-1 8.7 15 6.7 
9C-5-3 5.9 24 1.7 
68B1 1.2 2.2 0.72 
68B3 2.0 0.6 1.9 
Bc3T3 100.0 81 100.0 
LMTK" 0.2 ND 1.0 
A7B4b ~ 80 ND 76 
WTBla ~ 130 ND ND 
'ZOne-hour labeling period at 37°C. 
~Determined by autoradiography. 
~SV40-transformed Be3T3 cells not selected for drug 
resistance, 
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to the uptake of [3H]BrdU for all cell lines 
tested (data not shown). 
TK activity in BT-resistant cells, Bc3T3 
cells, and SV40-transformed Bc3T3 cells not 
selected for drug resistance paralleled the 
BrdU uptake results. TK activity in BT- 
resistant cells ranged from 0.72% to 6.7% of 
the activity exhibited by untransformed Bc3T3 
cells. An SV40-transformed cell line not 
selected for drug resistance possessed 76% 
of wild-type Bc3T3 TK activity, while L M T K  
cells, a thoroughly studied stable mutant cell 
line deficient in TK, expressed only 1% of the 
Bc3T3 level of TK. Mammalian cells take up 
thymidine via two systems: a low-affinity 
nonconcentrative facilitated diffusion pro- 
cess that is a general pathway for nucleoside 
uptake (38, 39) and a high-affinity concentra- 
tive process dependent on the presence and 
specific type of TK expressed in the mamma- 
lian cell (39). The difference observed in 
BrdU uptake between BT-resistant ceils and 
Bc3T3 at low substrate concentration proba- 
bly reflects a difference in the TK-dependent 
high-affinity system, which suggests that the 
key defect in BT-resistant cells is a loss of TK 
activity that both prevents BrdU and TFT 
incorporation and reduces BrdU (and proba- 
bly TFT) uptake. 
Autoradiography was performed on cell 
monolayers of BT-resistant cells and Bc3T3 
cells exposed to medium containing 
[3H]BrdU. The nuclei in the Bc3T3 monolay- 
ers were uniformly heavily labeled, while the 
majority of cell nuclei in the BT-resistant cell 
monolayers were unlabeled. However, the 
BT-resistant cell lines exhibited a back- 
ground of heavily labeled cell nuclei. The 
9C-4-1 and 9C-5-3 subclones had 15% and 
24% heavily labeled nuclei, while 68B1 and 
68B3 had 2.2% and 0.6% heavily labeled 
nuclei, respectively. The results of the autora- 
diography experiments are consistent with 
the TK activity and BrdU uptake observa- 
tions and indicate that the small amount of 
residual TK activity and BrdU uptake is due 
to a small fraction of cells with near-normal 
phenotype rather than a uniform low level of 
TK activity in all cells. Since the drug- 
resistance phenotype is relatively unstable 
and cloned cell populations (9C series) are 
heterogeneous in phenotype, the drug- 
resistant cells may not be mutants at the level 
of DNA sequence but may be due to an 
epigenetic phenotype switching event in- 
duced by SV40 infection. 
Effect of SV40 Infection on Thioguanine 
Resistance in Mouse-Human Hybrid Cells. To 
test for SV40-induced chromosome loss or 
chromosome rearrangement, we examined 
the frequency of thioguanine-resistant cells 
in SV40-infected 157BnpT-1B cells that 
express high levels of SV40 T antigen after 
infection. These hybrid cells have two select- 
able markers on the human X chromosome: 
HPRT, which confers sensitivity to 6TG and 
resistance to HAT medium, and C1HR, a 
locus which confers resistance to 38.5°C, 
which is the nonpermissive temperature of 
the heat-sensitive mutant mouse cell used to 
construct the hybrid. These two selectable 
markers on the same chromosome permit a 
direct test for whole chromosome loss in- 
duced by any potentially clastogenic agent, 
since loss of the whole human X chromo- 
some results in a cell that is simultaneously 
6TG resistant, HAT sensitive, and tempera- 
ture sensitive. 
SV40-infected hybrid cells that survive 
6TG selection may have undergone any of a 
number of mutagenic events capable of 
conferring resistance to 6TG, such as whole 
X chromosome loss, breakage or rearrange- 
ment of the X chromosome followed by loss 
or inactivation of the HPRT locus located in 
the distal long arm of the human X chromo- 
some, insertional inactivation of the HPRT 
locus by SV40, or other mutagenic event 
(base substitution, deletion, etc.) in the 
structural or regulatory region of the HPRT 
locus. It is assumed that the probability of 
simultaneous structural gene mutations at 
two loci is low compared to the probability of 
whole chromosome loss. Interspecific mouse- 
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human hybrids generally exhibit preferential 
loss of human chromosomes at a rate 
substantially higher than the spontaneous 
frequency of 6TG-resistant mutants in mam- 
malian cells (40-42). 
SV40-infected hybrid cells were tested 
for the frequency of 6TG-resistant cells at 
33°C seven days after treatment at 33°C with 
a mock cell lysate, cotchicine at 0.015 p~gjmI 
for five days, or SV40 at multiplicities of 
infection of 1700, 5200, or 15,000 for five 
days. Cells treated with colchicine, an agent 
known to induce chromosome loss, exhibited 
a 7.8-fold increase in the frequency of 
6TG-resistant cells relative to the mock 
lysate control, while cells infected with SV40 
at the highest multiplicity of infection showed 
a 3.5-fold increase (Table 2). The effect of 
SV40 infection on the frequency of 6TG- 
resistant hybrid cells appeared to be propor- 
tional to the multiplicity of infection, since 
only a marginal increase was noted at an 
intermediate multiplicity of infection and no 
effect was observed at the lowest multiplicity 
of infection. 
To determine whether the increase in 
6TG-resistant cells represented chromosome 
loss, an experiment was performed in which 
the frequency of 6TG-resistant cells was 
determined at the permissive temperature 
and at the nonpermissive temperature. In 
this experiment, colcemid was used instead 
of colchicine. Colcemid produced a dramatic 
56-fotd increase in the frequency of 6TG- 
resistant cells at the permissive temperature. 
Greater than 99% of the colcemid-induced 
6TG-resistant hybrids were heat sensitive, 
which demonstrated that the 6TG-resistant 
cells lacked both the HPRT and C1HR loci 
and probably arose through colcemid- 
induced loss of the human X chromosome. 
SV40 infection produced a 12.7-fold increase 
in the frequency of 6TG-resistant hybrids at 
the permissive temperature and a 2.8-fold 
increase in the frequency of 6TG-resistant 
hybrids at the nonpermissive temperature. 
These observations indicated that most of 
the 6TG-resistant mutants induced by SV40 
probably represented human X chromosome 
loss events because 80% of the 6TG-resistant 
hybrids have also lost the X-linked heat- 
resistance locus C1HR. Twenty percent of 
the SV40-treated 6TG-resistant hybrids have 
the C1HR locus and represent X chromo- 
some rearrangement events or mutagenesis 
at the HPRT locus. 
DISCUSSION 
We found SV40 to be nonmutagenic or 
weakly mutagenic in cell lines expressing T 
antigen at levels ranging from undetectable 
to moderate. The lack of ability to detect 
mutagenic effects may be due to: the ability 
of the host cell to absorb, internalize, and 
uncoat virions; host cell effects on virus gene 
expression; host cell response to viral gene 
products; the linkage arrangement of nones- 
sential selectable genes with respect to 
essential genes; metabolic cooperation and 
cell density at selection; and gene copy 
number of loci subjected to selection (43, 
44). The modest mutagenic effects of SV40 
noted by others are probably not significantly 
different from the small increases we ob- 
served in the frequency of 6TG-resistant cells 
in SV40-infected cultures of CHOK1, 462- 
10, or CHEF. 
The cell lines in our study that had the 
highest infection rates, Bc3T3 and the 
mouse-human hybrid, exhibited the most 
significant levels of induced drug-resistant 
cells (viz. 10-3-10-4). The SV40-induced 
changes in TK gene expression in Bc3T3 cells 
indicate that this virus can alter the host cell 
phenotype by epigentic processes that result 
in destabilization of gene expression. The 
observation that SV40 induces whole chromo- 
some loss demonstrates a clastogenic effect 
of this virus capable of inducing aneuploidy 
in infected cells. Epigenetic processes lead- 
ing to unstable phenotype switching and 
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aneuploidy may contribute to cell transforma- 
tion and variations in the transformed cell 
phenotype. 
Phenotype Switching. The TK- Bc3T3 
cell lines resulting from SV40 infection 
appear to be mixtures of cells lacking TK 
actMty and cells that contain normal or 
near-normal levels of TK. Since subcloning 
fails to eliminate the background of TK + cells 
from TK- BT-resistant cells, these TK + ceils 
must arise through some type of phenotypic 
switching event. Phenotypic switching at a 
high frequency at the TK locus has been 
observed in both mouse and human cells. 
Bastow et. al., (45) and Ostrander et. al., (46) 
reported that LMTK- cells containing an 
active herpes simplex (HSV) TK gene yielded 
TK- clones at a high frequency. Ostrander 
et. al., (46) observed 5-azac3~tidine-inducible 
phenotypic switching from HSV TK ~ to HSV 
TK +, which appeared to be associated with 
gene methylation. Harris (47) and Wise and 
Harris (44) have shown that expression of the 
cellular TK gene in Chinese hamster V79 
cells may be controlled by methylation and 
that methylation of the cellular TK gene may 
be involved in the isolation of T K  mutants. 
The molecular nature of the phenotype 
switching event in 9C and 68B cell lines 
derived from Bc3T3 is unknown but may 
invoh, e an epigenetic process such as gene 
methylation rather than a genetic change in 
nucleotide sequence. Such an epigenetic 
effect might be transdominant and lead to 
the appearance of TK- cells at a high 
frequency despite the fact that the TK gene is 
an autosomal gene and would be expected to 
be present in Bc3T3 hypotetraploid cells at 
two to four copies per cell. 
Epigenetic Effects of SV40. Epigenetic 
effects of SV40 on host ceil gene expression 
have been described by Soprano et al. (48), 
who noted an SV40 T antigen-dependent 
activation of human rDNA genes in mouse- 
human hybrid cells. Parker et al. (49) found 
that the alpha 2(1) procollagen gene was 
transcriptionally inactivated in SV40-trans- 
formed WI38 cells but was active in normal 
WI38. Matsumura et al. (50, 51) reported 
that human diploid fibroblasts exhibit declin- 
ing levels of methylation during passage but 
that methylation levels are maintained in 
SV40-transformed precrisis human diploid 
fibroblasts. During the course of studies 
investigating the possible role of methylation 
in inactivation of tumor suppressor genes, de 
Bustros et al. (52) discovered that SV40- 
infected human cells exhibit altered methyta- 
tion in the region of the calcitonin gene. 
Epigenetic effects of SV40 on the host cell 
genome may play a role in mediating 
SV40-induced cell transformation. 
Clastogenic Effects of SV40. We ex- 
ploited the properties of a hybrid cell line 
that contains a human X chromosome carry- 
ing two selectable markers on a mouse L-cell 
background. The human X chromosome is 
dispensable when the hybrid cells are grown 
under nonselective conditions, which permits 
these cells to be used to test for clastogenic 
agents using X-linked selective markers. In 
contrast, whole X chromosome loss in 
CHOK1, 462-10, and CHEF is likely to be 
lethal, and these cell lines are not suitable for 
testing virus-induced whole chromosome loss 
using selectable X-linked markers. 
When the hybrids were treated with low 
concentrations of a drug known to produce 
whole chromosome loss or nondisjunction, a 
substantial increase in the frequency of 
6TG-resistant heat-sensitive cells was ob- 
served, which is indicative of whole chromo- 
some toss. After SV40 infection, the hybrid 
cells also exhibited an increase in human X 
chromosome loss, albeit not as great as the 
loss produced by colcemid treatment. This 
clastogenic effect of SV40 could mimic 
various classical chemical mutagens such as 
ethyl methane sulfonate by uncovering preex- 
isting recessive mutations in heteroploid 
cultured cells. Ornitz et al. (53) described 
two stages in the development of SV40- 
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induced pancreatic adenocarcinoma in trans- 
genic mice: an initial preneoplastic stage, in 
which T antigen is expressed and morpholog- 
ical progression occurs from hyperplasia to 
dysplasia, and a second stage characterized 
by tumor nodules with aneuploid DNA 
contents. These investigators suggest that the 
transformation events that they observed 
may occur coincidently with chromosome 
loss. 
SUMMARY 
Our results demonstrate that SV40 may 
induce whole chromosome toss in addition to 
the well-known ability of SV40 to induce 
chromosome rearrangements and structural 
abnormalities. Our observation of SV40- 
induced unstable TK- mutants in Bc3T3 cells 
demonstrates a new epigenetic effect of 
SV40 infection on the cell phenotype. The 
extent of SV40 epigenetic effects on host cell 
transformation remains to be elucidated. In 
view of the ubiquitious presence of papovavi- 
ruses related to SV40 in the human popula- 
tion (54, 55) it may be of interest to 
determine if other papovaviruses are capable 
of inducing similar effects. 
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